00 : 00 / 05: 00 (Preview)
Extended half-life (EHL) recombinant factor VIII drugs promise excellent prophylaxis by reducing dose frequency, enhancing compliance, and improving quality of life while maintaining safety and efficacy. This session will provide a detailed overview of the rationale for developing EHL coagulation factors and their use in the treatment of haemophilia A, with a focus on the indications, efficacy, and safety of the existing EHL-FVIII products.
Advisor for Hemophilia, Govt. of NCT Delhi and Medical Consultant, Maulana Azad Medical College, New Delhi
Associate Professor and HOD, Department of Pediatric Hematology-Oncology | Post Graduate Institute of Child Health, Noida
Professor & Director | Institute of Haematology & Transfusion Medicine, Kolkata
Department of Hematology, Nilratan Sircar Medical College.
Advisor for Hemophilia, Govt. of NCT Delhi an...
Associate Professor and HOD, Department of Pe...
Professor & Director | Institute of Haematolo...
Department of Hematology, Nilratan Sircar Med...
Medflix is a new platform by PlexusMD, India's most active and trusted doctor community. On Medflix, you can discover live surgeries, discussions, conferences and courses from some of the top doctors and institutions across the world. Join clubs in your areas of interest and access hundreds of amazing live discussions everyday.
* This is a Takeda sponsored webinar.
This information is solely intended for the use of Registered Medical Practitioner and Hospital only. This information should not be used or shared or distributed to any other person/party and should be strictly by the intended parties for the intended purposes only. For more information, please refer to full Prescribing Information.
This material contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution.
TAKEDA and the “TAKEDA logo are trademarks or registered trademarks of Takeda Pharmaceutical Company Limited.” For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory.
Copyright © 2020 Takeda Pharmaceutical Company Limited. All rights reserved.
Contact us: Baxalta Bioscience India Pvt. Ltd. (part of Shire)
Shire is part of Takeda Pharmaceutical Company Ltd.
6th Floor, Tower-C, Building No.8, DLF Cyber City, DLF Phase-II,
Gurgaon-122002, Haryana, India
Takeda - Better Health, Brighter Future
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.